| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Networking for Success: The 3 Phases of Small Talk |
|
Main Subject - Networking for Success: The 3 Phases of Small Talk
In my mind, small talk basically consists of 3 phases:
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rn give you some concrete takeaway strategies that you can apply immediately for each. Phase 1: The Ice Breaker So you attend a networking event… you make eye contact with someone you want to mee ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t, you approach them and introduce yourself… now what? Well having a few powerful, open-ended ice breaker questions should certainly do the trick. For example:
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. roverbial, “So Jeff, what do you do?” In other words “Jeff, what business are you in? Now people love talking about themselves and their business so the idea here is to get them started talking. Most peopl here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e also love to hear the sound of their own voice so the ice breaker question is critical and essentially sets the tone and potential for the conversation.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro , what brings you here today?”
Now notice on these sample ice breaker questions I’ve repeated the person’s name. First off by doing this it will help burn that person’s name into my head so I don’ ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t forget it. Secondly, people love the sound of their own name – so don’t be afraid to use it throughout your conversation. Phase 2: Get To Know You Better Depending on the results of the ice br easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi eaker questions you should by now be able to determine whether or not it makes sense to get to know this person better. If not, simply skip this phase and go into your graceful exit. But if you do see a syn nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ergy here, by all means try some of these again open-ended, getting to know you better questions:
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi /li>
Now you can use one, two, all of these questions, or more if the situation permits. However, be careful here not to dominate and monopolize someone’s time. If you’re at a networking event, there’ ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s a good chance that they’re there to network and meet other people as well, so it may make sense to go to the graceful exit phase and encourage that you two get together in the near future. Phase 3: Grac dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod eful Exit It’s vastly important how you leave a conversation – as this is the last impression you make on that person. We’re not looking to create any animosity here by rudely blowing someone off. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin The key here is as this phase’s title states, is to exit gracefully. A key difference between the types of questions or statements you make in this phase as opposed to the previous two phases is that now you tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen shift to using close-ended ones. For example:
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Cindy I’d like you to meet Jeff. Jeff’s in the xyz industry as well and I just felt that you two should meet.” Now they exchange pleasantries and you immediately exit the conversation by saying something li ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ke, “Well you two probably have a bunch to talk about. Cindy I’ll catch up with you later and Jeff, it was great meeting you.”
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ynergy between what you and I do. Can I give you a call next week to set up some time to talk further?
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de this is quite an event don’t you think? Well we should probably keep moving… it was great meeting you Jeff!
So now you're aware of and armed with some actual strategies for the 3 phases of smal elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip l talk. The key now is to get in the game and practice, practice, practice and you too can see the results you would like for your business.
© 2006 Online Marketing Muscle -- All Rights Reserved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Intelligence in Taxation The Added Effectiveness of Promotional Products in Your Marketing Plan
|